2023
DOI: 10.1158/0008-5472.c.6513774.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Data from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination

Abstract: <div>Abstract<p><i>MET</i> exon 14 skipping alteration (<i>METΔ14Ex</i>) is an actionable oncogenic driver that occurs in 2% to 4% of non–small cell lung cancer (NSCLC) cases. The precise role of <i>METΔ14Ex</i> in tumor progression of NSCLC is poorly understood. Using multiple isogenic <i>METΔ14Ex</i> cell models established with CRISPR editing, we demonstrate that METΔ14Ex expression increases receptor kinase activity and downstream signaling by imp… Show more

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles